ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1401	National Cancer Institute	Html	en	Depression (PDQ®)–Patient Version	Expert-reviewed information summary about the diagnosis, assessment, and treatment of depression in adults and children who have cancer.	cancer treatment 0.651741 talk therapy 0.584553 cancer reacts 0.573578 PDQ cancer information 0.709592 specific symptoms 0.575944 children 0.567594 clinical trials 0.590596 major depression 0.717529 cancer information summary 0.661683 social support 0.596519 family members 0.586314 clinical trial 0.577701 breast cancer prevention 0.582269 risk factors 0.576392 cancer patients 0.640384 suicide 0.586542 cancer diagnosis 0.641499 daily life 0.565808 usual activities 0.591649 nerve cells 0.617277 symptoms 0.713409 NCI PDQ cancer 0.615822 anxiety 0.567307 effects 0.576095	treatment 0.684675 medicines 0.607072 Cancer Information Service 0.595317 personal history 0.608756 pancreatic cancer 0.571142 treatment clinical trials 0.568602 National Cancer Institute 0.658955 health care 0.575207 Palliative Care Editorial 0.599921 tricyclic antidepressants 0.564862 cancer pain 0.568074 new treatment 0.572603 Cancer Care page 0.585295 Care Editorial Board 0.601242 antidepressants 0.660082 active cancer treatment 0.606386 PDQ summary 0.608172 doctor 0.608478 cancer-related depression 0.600613 cancer information summaries 0.594088 comprehensive cancer information 0.593479 cancer 0.885163 depression 0.980341 reuptake inhibitors 0.578298	CLICK HERE
1440	National Cancer Institute	Html	en	Genetics of Colorectal Cancer (PDQ®)–Health Professional Version	Hereditary colorectal cancer syndromes include Lynch syndrome and several polyposis syndromes (familial adenomatous polyposis, MUTYH-associated polyposis, juvenile polyposis syndrome, Peutz-Jeghers syndrome, and serrated polyposis syndrome). Learn about the genetics, clinical manifestations, management, and psychosocial aspects of these and other hereditary colon cancer syndromes in this expert-reviewed summary.	hyperplastic polyps 0.725031 nondysplastic serrated polyps 0.656585 adenomatous polyps 0.691874 classic FAP burden 0.649593 colonic polyps 0.652581 colorectal cancer risk 0.652487 FAP patients 0.932715 colorectal cancer screening 0.641111 familial CRC risk 0.634448 duodenal adenomas 0.717785 polyps 0.898156 colorectal cancer 0.915758 large serrated polyps 0.681431 conventional hyperplastic polyps 0.657048 rectal cancer risk 0.636363 hereditary nonpolyposis colorectal 0.723285 CRC 0.676743 colorectal adenomatous polyps 0.677785 APC pathogenic variant 0.710503 familial adenomatous polyposis 0.637625 et al. 0.674027 adenomas 0.856618 study 0.666989 nonpolyposis colorectal cancer 0.748743 duodenal polyps 0.793499	polyp burden 0.773382 FAP family member 0.659403 hereditary colon cancer 0.646397 unselected CRC patients 0.633325 CpG island methylator 0.649466 Lynch syndrome patients 0.681837 pathogenic variants 0.757278 Advanced colorectal polyps 0.671186 serrated adenomas 0.645858 FAP families 0.629309 large adenomas 0.639406 Lynch syndrome 0.829151 FAP polyp burden 0.677536 colon cancer 0.807611 Abstract 0.653383 uncontrolled rectal polyps 0.639399 island methylator phenotype 0.649038 duodenal polyp burden 0.68665 FAP patients. 0.679148 SPS polyps 0.632287 family history 0.768195 cancer risk 0.699194 rectal cancer patients 0.661401 classic FAP 0.64982	CLICK HERE
1523	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	Peritoneal Cancer Prevention 0.227525 treatment 0.390762 cancer treatment 0.235396 Peritoneal Cancer Treatment 0.215309 cancer cells 0.337677 body 0.222684 PDQ cancer information 0.234419 ovarian epithelial cancer 0.590068 fallopian tube cancers 0.219247 fallopian tube 0.872006 advanced ovarian epithelial 0.202336 fallopian tube cancer 0.492956 National Cancer Institute 0.246576 primary peritoneal cancer 0.750448 clinical trials 0.486834	cancer information summary 0.212408 clinical trial 0.300455 new treatment 0.206874 PDQ Ovarian Epithelial 0.215884 ovarian cancer 0.427345 patients 0.208263 primary peritoneal cancers 0.298007 peritoneal cancer form 0.23692 Recurrent ovarian epithelial 0.234027 Hereditary ovarian cancer 0.23385 cancer clinical trials 0.21629 stage 0.222725 fallopian tubes 0.310827 cancer 0.950591 information 0.260881	CLICK HERE
1569	National Cancer Institute	Html	en	Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of mycosis fungoides (including Sézary Syndrome).	red blood cells 0.477836 cancer treatment 0.542958 body 0.529399 type 0.500535 mycosis fungoides 0.975868 electron beam radiation 0.477517 PDQ cancer information 0.525493 clinical trial search 0.486291 white blood cells 0.528751 abnormal blood cells 0.470219 clinical trials 0.793086 Natural killer cells 0.470828 cancer information summary 0.501852 clinical trial 0.600812 mycosis fungoides cells 0.530781 patients 0.476603 blood cells 0.579852 skin electron beam 0.532192 malignant tumor cells 0.48923 NCI PDQ cancer 0.469777 Treatment Option Overview 0.471891 total skin electron 0.534719 radiation therapy 0.663697 Treatment Editorial Board 0.471648 beam radiation therapy 0.484689	treatment 0.659413 myeloid stem cell 0.465408 immature blood cells 0.46931 photodynamic therapy 0.471883 Recurrent mycosis fungoides 0.52314 mycosis fungoides spreads 0.498418 skin 0.583221 cancer cells 0.698589 lymphoid stem cell 0.465897 treatment clinical trials 0.487816 blood stem cells 0.499083 National Cancer Institute 0.538216 sézary syndrome 0.849117 normal cells 0.5004 new treatment 0.509312 Skin Cancer Treatment 0.502202 External radiation therapy 0.473547 metastatic mycosis fungoides 0.5 non-hodgkin lymphoma 0.536949 bone marrow 0.486285 cancer clinical trials 0.50691 stage 0.517644 cancer 0.856203 information 0.542975	CLICK HERE
1578	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	treatment 0.350503 cancer cells 0.273747 salivary gland tumors 0.252711 body 0.202362 Recurrent salivary gland 0.246617 PDQ cancer information 0.209396 clinical trial search 0.221183 National Cancer Institute 0.225088 clinical trials 0.502843 clinical trial 0.428553 fast neutron radiation 0.275402 patients 0.211575	salivary glands 0.27815 small salivary gland 0.219313 major salivary gland 0.219682 salivary gland cancer 0.977675 cancer clinical trials 0.23079 lymph node 0.201663 radiation therapy 0.594263 salivary gland cancers 0.255838 information 0.215378 diagnose salivary gland 0.246491 Minor salivary gland 0.204078 neutron radiation therapy 0.270686	CLICK HERE
1594	National Cancer Institute	Html	en	Gallbladder Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gallbladder cancer.	Primary gallbladder cancer 0.47032 bile ducts 0.484867 tissue 0.379314 body 0.404589 Gallbladder Cancer Treatment 0.453363 PDQ cancer information 0.441195 clinical trial search 0.374973 bile duct 0.37352 Endoscopic stent placement 0.366691 nearby lymph nodes 0.402642 cancer information summary 0.414802 clinical trial 0.522846 breast cancer prevention 0.364901 liver 0.416883 gallbladder surgery 0.402266 gallbladder stores 0.412552 patients 0.384079 blood vessels 0.366084 metastatic gallbladder cancer 0.515618 Unresectable cancer 0.362347 treatment clinical trial 0.366014 NCI PDQ cancer 0.38278 radiation therapy 0.532352 Treatment Editorial Board 0.368907	small intestine 0.483884 treatment 0.503531 gallbladder cancer 0.938706 transhepatic biliary drainage 0.367562 new cancer treatments 0.372521 NCI-supported cancer 0.364603 cancer cells 0.513548 Cancer Information Service 0.372954 common bile duct 0.365877 treatment clinical trials 0.389845 gallbladder cancer cells 0.455848 National Cancer Institute 0.416909 new treatment 0.406145 External radiation therapy 0.364544 stage gallbladder cancer 0.491411 ) layer. 0.384877 clinical trials 0.742882 Cancer Care page 0.364553 Blood. The cancer 0.370595 cancer research process 0.366097 cancer clinical trials 0.40814 tumor 0.374261 cancer information summaries 0.371259 comprehensive cancer information 0.371502	CLICK HERE
1810	National Cancer Institute	Html	es	Tratamiento del cáncer de páncreas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de páncreas.	resectable pancreatic 0.421757 Sin embargo 0.468358 largo plazo 0.439685 chemotherapy following curative 0.48776 Tumor Study Group 0.478506 curative resection 0.550476 fase iii 0.665649 Natl Cancer Inst 0.419755 after curative resection 0.455925 Arch Surg 0.451242 effective adjuvant combined 0.42796 gemcitabina versus 0.464125 quimiorradioterapia posoperatoria 0.420132 Gastrointestinal Intergroup 0.4265 Cameron JL 0.507923 periampullary region 0.42716 patients with 0.44756 randomized controlled 0.421891 Conlon KC 0.442167 Lillemoe KD 0.42689 EORTC gastrointestinal tract 0.428698 meses vs 0.421884 gastrointestinal tract 0.431387 following curative resection 0.474649 Yeo CJ 0.5451	M0 T2 0.428111 M0 T1 0.424975 chemotherapy after resection 0.463442 Regine WF 0.420404 M0 T3 0.428453 pancreatic cancer 0.97706 as risk factors 0.421112 postoperative adjuvant chemoradiation 0.455288 versus gemcitabina 0.456328 Surg Oncol 0.435512 patients with resected 0.42485 Gastrointestinal Tumor Study 0.48648 páncreas estadio 0.439198 régimen off 0.443587 Grochow LB 0.426604 estadio iii 0.623435 Abrams RA 0.46019 Gy XRT 0.450407 Adjuvant chemotherapy with 0.456373 Stocken DD 0.455773 Oncology Group 0.420611 adjuvant combined 0.442249 quimioterapia posoperatoria 0.432032 5-fluorouracil after curative 0.42675	CLICK HERE
2035	National Cancer Institute	Html	es	Prevención del cáncer de próstata (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre los factores que pueden influir en el riesgo de cáncer de próstata y sobre la investigación dirigida a la prevención de esta enfermedad.	Cancer Events Trial 0.485531 principal hormona 0.450019 hiperplasia prostática benigna 0.693996 siguientes aspectos 0.54196 voluntarios sanos 0.443459 sistema urinario masculino 0.492083 protección baje 0.460121 sexuales masculinas 0.54225 características sexuales masculinas 0.494615 productos lácteos 0.532437 National Cancer Institute 0.461613 causa problemas 0.446148 siguientes riesgos 0.444876 alto contenido 0.439101 vitamina e 0.679303 Instituto Nacional 0.499716 hormonas masculinas 0.456898	hormonas sexuales masculinas 0.490983 Cancer Prevention Trial 0.881744 próstata.ampliar próstata 0.748136 ensayo pcpt 0.447994 siguientes factores 0.946442 Physician Data Query 0.60903 Estados Unidos 0.553599 suficiente ejercicio 0.453444 prevención revisa 0.462505 Antecedentes familiares 0.554865 PDQ Prevención 0.512729 aparato reproductor masculino 0.494928 Prostate Cancer Prevention 0.495264 suficiente folato 0.56107 Prostate Cancer 0.530877 siguientes sumarios 0.505076	CLICK HERE
3423	National Cancer Institute	Html	es	Tintes para el cabello y el riesgo de cáncer	Hoja informativa que analiza las investigaciones sobre la posible conexión entre los tintes para el cabello de uso personal y el cáncer.	Garcia-Closas M 0.306371 Harling M 0.306346 La Vecchia C 0.308404 American Medical Association 0.308091 Personal permanent 0.308814 Costantini AS 0.305724 pequeño aumento 0.306764 lymphoid neoplasms 0.305705 case-control study 0.330749 sustancias químicas llamadas 0.319289 linfoma no-Hodgkin 0.315605 IARC Monographs 0.307567 New England bladder 0.317677 dye products 0.311357 Benvenuti A 0.306313 Occupational Health 0.305772 Sanjose S 0.317218 Estados Unidos 0.315003 resultados contradictorios 0.358008 hematolymphopoietic malignancies 0.305757 PubMed Abstract 0.927635 on carcinogenicity 0.306299 International Agency 0.31736 International Journal 0.345823 análisis conjunto 0.313039	Nieters A 0.306464 Bolt HM 0.305479 Critical Reviews 0.305548 Nienhaus A 0.305624 leucemia aguda 0.319649 non-Hodgkin lymphoma 0.305903 is not 0.31478 Carcinogenic Risks 0.30569 aminas aromáticas 0.321464 Dulon M 0.30623 Epidemiology Biomarkers 0.309054 Thun MJ 0.305441 Etminan M 0.306466 Hamann CR 0.305758 determinados tipos 0.306529 Kogevinas M 0.306372 Aben KK 0.305435 Gago-Dominguez M 0.314868 Sandler DP 0.305457 case-control study from 0.31306 Some Aromatic Amines 0.30908 Schablon A 0.305625 Montes-Martinez A 0.305837 Decarli A 0.305736	CLICK HERE
3567	National Cancer Institute	Html	en	NCI-Designated Cancer Centers	NCI-designated cancer centers are at the forefront of NCI-supported cancer research efforts at universities and cancer research centers across the United States.	Basic Laboratory Cancer 0.40308 cancer prevention 0.219474 United States 0.258952 promising laboratory discoveries 0.246618 successful investigator-initiated grants 0.242213 NCI grant funding 0.273266 cancer center investigators 0.372566 Cancer Centers conduct 0.328404 university medical centers 0.293855 research capabilities 0.206064 individual cancer center 0.29193 fosters cancer programs 0.290926 NCI Cancer Centers 0.39489 cutting-edge cancer treatments 0.306989	cancer research effort 0.342261 Comprehensive Cancer Centers 0.42681 NCI-Designated Cancer Center 0.361383 new treatments 0.264162 cancer patients 0.223724 cancer diagnosis 0.215839 basic laboratory research 0.296921 cancer centers 0.970403 substantial transdisciplinary research 0.27523 cancer clinical trials 0.286407 Laboratory Cancer Centers 0.418647 cancer survivors 0.215279 research studies 0.213208	CLICK HERE